Compare XENE & OUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XENE | OUT |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.5B |
| IPO Year | 2014 | 2013 |
| Metric | XENE | OUT |
|---|---|---|
| Price | $66.81 | $32.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $68.55 | $28.50 |
| AVG Volume (30 Days) | ★ 1.7M | 1.5M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | $311,000.00 | ★ $1,831,700,000.00 |
| Revenue This Year | N/A | $6.19 |
| Revenue Next Year | $2,496.48 | $3.08 |
| P/E Ratio | ★ N/A | $301.91 |
| Revenue Growth | N/A | ★ 0.04 |
| 52 Week Low | $30.00 | $16.64 |
| 52 Week High | $72.66 | $34.96 |
| Indicator | XENE | OUT |
|---|---|---|
| Relative Strength Index (RSI) | 64.47 | 51.35 |
| Support Level | $52.40 | $29.78 |
| Resistance Level | $72.66 | $34.05 |
| Average True Range (ATR) | 2.68 | 0.82 |
| MACD | 0.16 | -0.04 |
| Stochastic Oscillator | 55.27 | 19.55 |
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The company has two reportable operating segments: Billboard and Transit. It derives maximum revenue from Billboard Segment. The company geographically operates in United States and Canada, of which United States derive maximum revenue.